Enhancing solubility of deoxyxylulose phosphate pathway enzymes for microbial isoprenoid production

Microbial Cell Factories

Volumn 11, Issue , 2012, Pages

  Zhou, Kang ^a   Zou, Ruiyang ^a   Stephanopoulos, Gregory ^a,c   Too, Heng Phon ^a,b  

^a SINGAPORE MIT ALLIANCE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

Activity analysis; Deoxyxylulose phosphate pathway; Isoprenoids; Metabolic engineering; Protein solubility

Indexed keywords

1 HYDROXY 2 METHYL 2 BUTENYL 4 DIPHOSPHATE SYNTHASE; 2 C METHYL DEXTRO ERYTHRITOL 2,4 CYCLODIPHOSPHATE SYNTHASE; 4 DIPHOSPHOCYTIDYL 2C METHYL DERYTHRITOL SYNTHASE; DEOXYXYLULOSE PHOSPHATE; ISOPRENOID; MEVALONIC ACID; PHOSPHATE; SORBITOL; SYNTHETASE; UNCLASSIFIED DRUG;

ARTICLE; CELL INCLUSION; ENZYME ACTIVITY; METABOLIC ENGINEERING; PROTEIN EXPRESSION; SOLUBILITY;

BIOREACTORS; ENZYMES; ESCHERICHIA COLI; GERANYLTRANSTRANSFERASE; HUMANS; OXIDOREDUCTASES; RECOMBINANT PROTEINS; SOLUBILITY; TERPENES; TRANSFERASES; XYLOSE;

EID: 84868687578     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-11-148     Document Type: Article

References (37)

1. Ro DK, Paradise EM, Ouellet M, Fisher KJ, Newman KL, Ndungu JM, Ho KA, Eachus RA, Ham TS, Kirby J, et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 2006, 440(7086):940-943. 10.1038/nature04640, 16612385.
2. Ajikumar PK, Xiao WH, Tyo KE, Wang Y, Simeon F, Leonard E, Mucha O, Phon TH, Pfeifer B, Stephanopoulos G. Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science (New York, NY 2010, 330(6000):70-74.
3. Hunter WN. The non-mevalonate pathway of isoprenoid precursor biosynthesis. J Biol Chem 2007, 282(30):21573-21577. 10.1074/jbc.R700005200, 17442674.
4. Ajikumar PK, Tyo K, Carlsen S, Mucha O, Phon TH, Stephanopoulos G. Terpenoids: opportunities for biosynthesis of natural product drugs using engineered microorganisms. Mol Pharm 2008, 5(2):167-190. 10.1021/mp700151b, 18355030.
5. Westfall PJ, Pitera DJ, Lenihan JR, Eng D, Woolard FX, Regentin R, Horning T, Tsuruta H, Melis DJ, Owens A, et al. Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc Natl Acad Sci USA 2012, 109(3):E111-E118. 10.1073/pnas.1110740109, 3271868, 22247290.
6. Kim SW, Keasling JD. Metabolic engineering of the nonmevalonate isopentenyl diphosphate synthesis pathway in Escherichia coli enhances lycopene production. Biotechnol Bioeng 2001, 72(4):408-415. 10.1002/1097-0290(20000220)72:4<408::AID-BIT1003>3.0.CO;2-H, 11180061.
7. Alper H, Jin YS, Moxley JF, Stephanopoulos G. Identifying gene targets for the metabolic engineering of lycopene biosynthesis in Escherichia coli. Metab Eng 2005, 7(3):155-164. 10.1016/j.ymben.2004.12.003, 15885614.
8. Kang MJ, Lee YM, Yoon SH, Kim JH, Ock SW, Jung KH, Shin YC, Keasling JD, Kim SW. Identification of genes affecting lycopene accumulation in Escherichia coli using a shot-gun method. Biotechnol Bioeng 2005, 91(5):636-642. 10.1002/bit.20539, 15898075.
9. Yuan LZ, Rouviere PE, Larossa RA, Suh W. Chromosomal promoter replacement of the isoprenoid pathway for enhancing carotenoid production in E. coli. Metab Eng 2006, 8(1):79-90. 10.1016/j.ymben.2005.08.005, 16257556.
10. Jin YS, Stephanopoulos G. Multi-dimensional gene target search for improving lycopene biosynthesis in Escherichia coli. Metab Eng 2007, 9(4):337-347. 10.1016/j.ymben.2007.03.003, 17509919.
11. Wang C, Oh MK, Liao JC. Directed evolution of metabolically engineered Escherichia coli for carotenoid production. Biotechnol Prog 2000, 16(6):922-926. 10.1021/bp000124f, 11101317.
12. Lee PC, Mijts BN, Schmidt-Dannert C. Investigation of factors influencing production of the monocyclic carotenoid torulene in metabolically engineered Escherichia coli. Appl Microbiol Biotechnol 2004, 65(5):538-546.
13. Martin VJ, Pitera DJ, Withers ST, Newman JD, Keasling JD. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat Biotechnol 2003, 21(7):796-802. 10.1038/nbt833, 12778056.
14. Chang MC, Eachus RA, Trieu W, Ro DK, Keasling JD. Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nat Chem Biol 2007, 3(5):274-277. 10.1038/nchembio875, 17438551.
15. Harker M, Bramley PM. Expression of prokaryotic 1-deoxy-D-xylulose-5-phosphatases in Escherichia coli increases carotenoid and ubiquinone biosynthesis. FEBS Lett 1999, 448(1):115-119. 10.1016/S0014-5793(99)00360-9, 10217421.
16. Lee KK, Jang CS, Yoon JY, Kim SY, Kim TH, Ryu KH, Kim W. Abnormal cell division caused by inclusion bodies in E. coli; increased resistance against external stress. Microbiol Res 2008, 163(4):394-402. 10.1016/j.micres.2008.03.004, 18424015.
17. Wilkinson DL, Harrison RG. Predicting the solubility of recombinant proteins in Escherichia coli. Biotechnology (N Y) 1991, 9(5):443-448.
18. Davis GD, Elisee C, Newham DM, Harrison RG. New fusion protein systems designed to give soluble expression in Escherichia coli. Biotechnol Bioeng 1999, 65(4):382-388. 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.0.CO;2-I, 10506413.
19. Agostini F, Vendruscolo M, Tartaglia GG. Sequence-based prediction of protein solubility. J Mol Biol 2012, 421(2-3):237-241. 10.1016/j.jmb.2011.12.005, 22172487.
20. Tartaglia GG, Pechmann S, Dobson CM, Vendruscolo M. A relationship between mRNA expression levels and protein solubility in E. coli. J Mol Biol 2009, 388(2):381-389. 10.1016/j.jmb.2009.03.002, 19281824.
21. Hirose S, Kawamura Y, Yokota K, Kuroita T, Natsume T, Komiya K, Tsutsumi T, Suwa Y, Isogai T, Goshima N, et al. Statistical analysis of features associated with protein expression/solubility in an in vivo Escherichia coli expression system and a wheat germ cell-free expression system. J Biochem 2011, 150(1):73-81. 10.1093/jb/mvr042, 21478485.
22. Niwa T, Ying BW, Saito K, Jin W, Takada S, Ueda T, Taguchi H. Bimodal protein solubility distribution revealed by an aggregation analysis of the entire ensemble of Escherichia coli proteins. Proc Natl Acad Sci USA 2009, 106(11):4201-4206. 10.1073/pnas.0811922106, 2657415, 19251648.
23. Rodriguez-Villalon A, Perez-Gil J, Rodriguez-Concepcion M. Carotenoid accumulation in bacteria with enhanced supply of isoprenoid precursors by upregulation of exogenous or endogenous pathways. J Biotechnol 2008, 135(1):78-84. 10.1016/j.jbiotec.2008.02.023, 18417238.
24. Gonzalez-Montalban N, Garcia-Fruitos E, Villaverde A. Recombinant protein solubility - does more mean better?. Nat Biotechnol 2007, 25(7):718-720. 10.1038/nbt0707-718, 17621288.
25. Baneyx F, Mujacic M. Recombinant protein folding and misfolding in Escherichia coli. Nat Biotechnol 2004, 22(11):1399-1408. 10.1038/nbt1029, 15529165.
26. Panavas T, Sanders C, Butt TR. SUMO fusion technology for enhanced protein production in prokaryotic and eukaryotic expression systems. Methods Mol Biol 2009, 497:303-317. 10.1007/978-1-59745-566-4_20, 19107426.
27. de Marco A. Protocol for preparing proteins with improved solubility by co-expressing with molecular chaperones in Escherichia coli. Nat Protoc 2007, 2(10):2632-2639. 10.1038/nprot.2007.400, 17948006.
28. Xie X, Pashkov I, Gao X, Guerrero JL, Yeates TO, Tang Y. Rational improvement of simvastatin synthase solubility in Escherichia coli leads to higher whole-cell biocatalytic activity. Biotechnol Bioeng 2009, 102(1):20-28. 10.1002/bit.22028, 18988191.
29. Prasad S, Khadatare PB, Roy I. Effect of chemical chaperones in improving the solubility of recombinant proteins in escherichia coli. Appl Environ Microbiol 2011, 77(13):4603-4609. 10.1128/AEM.05259-11, 3127727, 21551288.
30. Zhou S, Grabar TB, Shanmugam KT, Ingram LO. Betaine tripled the volumetric productivity of D(-)-lactate by Escherichia coli strain SZ132 in mineral salts medium. Biotechnol Lett 2006, 28(9):671-676. 10.1007/s10529-006-0033-4, 16642307.
31. Kim CW, Han KS, Ryu KS, Kim BH, Kim KH, Choi SI, Seong BL. N-terminal domains of native multidomain proteins have the potential to assist de novo folding of their downstream domains in vivo by acting as solubility enhancers. Protein Sci 2007, 16(4):635-643. 10.1110/ps.062330907, 2203336, 17384228.
32. Han KY, Song JA, Ahn KY, Park JS, Seo HS, Lee J. Solubilization of aggregation-prone heterologous proteins by covalent fusion of stress-responsive Escherichia coli protein, SlyD. Protein Eng Des Sel 2007, 20(11):543-549. 10.1093/protein/gzm055, 17971396.
33. Kapust RB, Waugh DS. Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci 1999, 8(8):1668-1674. 10.1110/ps.8.8.1668, 2144417, 10452611.
34. Kyratsous CA, Silverstein SJ, Delong CR, Panagiotidis CA. Chaperone-fusion expression plasmid vectors for improved solubility of recombinant proteins in Escherichia coli. Gene 2009, 440(1-2):9-15. 10.1016/j.gene.2009.03.011, 2683908, 19328840.
35. Tsao CY, Wang L, Hashimoto Y, Yi H, March JC, Delisa MP, Wood TK, Valdes JJ, Bentley WE. LuxS coexpression enhances yields of recombinant proteins in escherichia coli in part through posttranscriptional control of GroEL. Appl Environ Microbiol 2011, 77(6):2141-2152. 10.1128/AEM.02347-10, 3067317, 21278275.
36. Xiang S, Usunow G, Lange G, Busch M, Tong L. Crystal structure of 1-deoxy-D-xylulose 5-phosphate synthase, a crucial enzyme for isoprenoids biosynthesis. J Biol Chem 2007, 282(4):2676-2682.
37. Sarkar G, Sommer SS. The "megaprimer" method of site-directed mutagenesis. Biotechniques 1990, 8(4):404-407.